Clinical trial
The Effect of Evolocumab on Infarct Size in Patients With ST-segment Elevation Myocardial Infarction; Prospective, Randomized, Open Label, Controlled Trial
NCT06081803 is registered in ClinicalTrials.gov with Sejong General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Evolocumab on Infarct Size in Patients With ST-segment Elevation Myocardial Infarction; Prospective, Randomized, Open Label, Controlled Trial
- Lead sponsor
- Sejong General Hospital
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- December 5, 2020
- Completion date
- December 31, 2025
- Enrollment
- 166 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.